The Duffy Null Phenotype - Addressing a Source of Discrimination in Cancer Care

Affiliation

• ¹ From the Dana-Farber Cancer Institute (A.H., L.E.M., G.A.A.), and the Center for Bioethics (A.H., G.A.A.), Harvard Medical School (A.H., L.E.M., G.A.A.) - both in Boston; and the Wolfson Institute of Population Health, Queen Mary University of London, London (S.P.H.).